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Does morbidity matter? Perceived
health status in explaining the share
of healthcare expenditures
Ebru Guven Solakoglua,* and Abdulkadir Civanb
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Turkey
bDepartment of Economics, Fatih University, Istanbul, Turkey
We argue that the demand for healthcare services can be better explained
by individual need based variables rather than by macro variables such as
the Gross Domestic Product (GDP) per capita and the share of public
healthcare expenditures. This study introduces a self-rated health variable
called morbidity that describes individual needs for health care – healthy
individuals need less health care than sick ones – and that is measured
through personal interviews conducted by the Organization for Economic
Co-operation and Development (OECD). In addition, stationary proper-
ties of the series are considered in order to understand the effect of shocks
to expenditure behaviour on health care. Stationary test results show that
we should not only use differenced values for the model variables but also
incorporate time-specific effects into the model. Using the appropriate
specification and accounting for the time effect, we find evidence
supporting the hypothesis that the share of healthcare expenditure in
GDP rises with the increased need for health care. The need for health care
is also found to be more important than per capita GDP when explaining
the change in the share of healthcare expenditures for the examined
countries.
Keywords: healthcare expenditures; morbidity; two-way model
JEL Classification: I10; H51; C23
I. Introduction
Former studies have concentrated on the effect of
income on healthcare expenditures. For example, in
his study of 13 Organization for Economic
Co-operation and Development (OECD) countries,
Newhouse (1977) found Gross Domestic Product
(GDP) to be the only factor that matters for
healthcare expenditure levels. However, countries
with similar levels of income offer different levels of
healthcare expenditure share in their GDP. Among
OECD countries, for example, annual per-capita
spending on healthcare services is 1535 USD in
Spain, 2297 USD in Finland and 5635 USD in the
USA; whereas, the share of health expenditure in
GDP is about 7.7% in Spain, 7.4% in Finland and
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15% in the USA.1 In other words, while countries
with a higher GDP tend to spend a greater propor-
tion of their GDP on health care, there is wide
variation, as GDP is not the sole factor influencing
health expenditure levels. Hence, many researchers
find it counterintuitive to conclude that income is the
only factor that determines the level of health
spending and look for new factors that may affect
healthcare expenditures (Kleiman, 1974; Leu, 1986;
Culyer, 1988; Gerdtham et al., 1992). For example,
Leu (1986) proposed that an increase in the size of the
public share would increase spending on healthcare
services. Two reasons for this proposition are the
typical incentives of bureaucrats for maximizing
institutional budgets on public choice literature and
the moral hazard problems of individuals on insur-
ance markets. As a proxy for the need for health care,
Leu (1986) used a ratio of the number of people
under 15 and over 65 to the rest of the population,
because very young and very old people generally
require more medical attention. Along with income
and public financing, Gerdtham et al. (1992) found
significant effects of urbanization for 19 OECD
countries. A much more ambitious study follows by
Gerdtham et al. (1998) in which they examined the
effects of different institutional structures and social
and behavioural dynamics on health expenditure
levels, using data for 22 OECD countries for the
period 1970 to 1991. They found that income,
tobacco consumption per capita and the percentage
of public in-patient care expenditure in total expen-
diture had positive effects on healthcare expenditures.
Recent studies, however, rather than questioning
existing and/or additional factors that may explain
healthcare expenditures, focus on the appropriateness
of the econometric methods used in the estimations
(Hansen and King, 1996; Blomqvist and Carter, 1997;
McCoskey and Selden, 1998; Gerdtham and
Lothgren, 2000; Roberts, 2000). While many of
these studies question the stationary properties of
using levels in regressions, some question the simul-
taneity problem in the models.2
This study introduces a new indicator as a proxy
for the need for healthcare in order to explain the
share of healthcare expenditures in OECD countries,
along with existing factors that are widely discussed
in the literature. This is a relatively direct measure,
when compared to the existing variables for the need
for health care: that is, the ‘perceived health status
(morbidity)’ measure. This morbidity variable was
measured in personal interviews conducted by the
OECD by asking the respondent: ‘Would you say
your health is excellent, very good, good, fair or
poor?’ The ratio of the population who answered that
his/her health status was good, very good or excellent
is reported as the morbidity variable. We believe this
measure to be a better proxy than the other measures
for estimating the need for health care.3 By using this
variable in our estimations, we place the arguments in
a more individual/self-framework in explaining the
(demand for) healthcare expenditures.
The remainder of this article is organized as
follows: Section II describes the data and the model
along with the discussions of the appropriate
specification of the model. Section III discusses the
stationary process and employs the two-way panel
model; the estimation results are also presented in this
section. Section IV provides our conclusions and
suggestions for further research.
II. Data and the Estimation
The data were obtained from the OECD Health Data
(2006) database, released in October 2006. This
database includes extensive health and health systems
information at a micro-level for 30 OECD countries.
Among 10 main parts of healthcare statistics, we
focus on the variables regarding self-reported per-
ceived health status (morbidity), expenditure on
health (total and public expenditures), demographic
references (population age structures) and economic
references (GDP).
As our main concern is the effect of perceived
health status – morbidity – by individuals, we
consider five OECD countries: Finland, the
Netherlands, Sweden, the US and the UK in our
estimations. Morbidity data were available from 1983
to 2004 for these countries, with no missing infor-
mation except for the UK, which presented data from
1991 to 2004. Other OECD countries present mor-
bidity variables, but data are scattered for these
1OECD Health Data (2006). GDP per-capita values for 2006 for Spain, Finland and USA were about 27K, 40K and 44K
USD, respectively, in 2006.
2As health care is a normal good, for example, a higher per-capita GDP results in an increase in per-capita healthcare
expenditures. In addition, higher healthcare expenditures can be regarded as a positive investment in human capital, and, in
turn, as an input to production, which causes an increase in GDP. Healthier individuals are more energetic and physically and
mentally robust, and thus more productive. They are also less likely to be absent from work due to illness.
3 See McGee et al. (1999), Burstrom and Fredlund (2001), Heistaro et al. (2001) and Hillen et al. (2000) for the positive
relationship between self-rated and actual health outcomes.


























countries, and hence, we exclude them from our
data set.
We explain the healthcare expenditures in terms of
the share of healthcare expenditures in GDP. The
first explanatory variable in our model is GDP per
capita. We expect to see that the share of healthcare
expenditures in GDP increases as a nation gets
wealthier. The second and third variables are the
share of public healthcare expenditures in total
healthcare expenditures and the share of elderly
people in total population. In general, old and very
old require more health care than young and middle
aged. Many studies use the percentage of population
over 65 as a proxy for this demographic shift. Most
studies have concluded that ageing societies are
spending more on health services.4 The last variable
in our model is our primary interest ‘morbidity’. Even
though it is almost certain that other factors includ-
ing lifestyle of individuals and disease incidences,5
environment and climate of the countries can affect
health spending, data availability and other econo-
metric problems have caused us to limit our analysis
on our main interest ‘morbidity’. Table 1 presents
descriptive statistics for these variables.
Among these variables both healthcare expenditure
and GDP exhibit nonstationary series (Hansen and
King, 1996; Blomquist and Carter, 1997; Gerdtham
and Lothgren, 2000). However, we should note that
the reliability and accuracy of the health expenditure
data have been questioned by many researchers.
Especially heterogeneous definition of the ‘health
care’ across countries and across time for the same
country is a widespread problem. For example,
expenditure for nursing homes are included in statis-
tics of some countries while is not included in other
countries.6 Nevertheless, all the variables in our
model exhibit strong trends and are not stationary.
Nonstationarity invalidates classical estimation pro-
cedures, which ignore the time-series properties of the
variables, leading to inconsistent estimates.
Therefore, a naive application of regression analysis
may yield spurious results.
Stationarity properties of the series are essential for
understanding the nature of shocks to the expendi-
ture behaviour on health care. Differencing or
de-trending can produce stationary series, and tests
can be performed using a conventional t-test with a
revised set of critical values that were derived by
Table 1. Descriptive statistics of dependent and independent variables for five countries
Variables Finland The Netherlands Sweden UK USA
Share of health care
expenditures in GDP
Mean 7.40 7.93 8.50 6.73 12.51
Median 7.25 7.90 8.35 6.90 13.10
Min 6.70 7.10 8.10 5.90 9.90
Max 9.00 9.20 9.30 8.10 15.30
GDP per capita Mean 19 889 21 900 21 201 19 562 26 707
Median 18 269 21 134 19 902 18 410 26 040
Min 12 004 12 419 12 995 10 669 15 008
Max 29 778 32 978 31 139 30 822 39 772
Share of public healthcare expenditures
in total healthcare expenditures
Mean 77.6 67.4 87.7 83.8 42.8
Median 76.5 67.5 87.2 83.9 43.6
Min 75.1 62.3 84.9 80.4 39.6
Max 81.1 73.6 91.6 87.4 45.7
Share of elderly people
in total population
Mean 0.138 0.129 0.174 0.156 0.123
Median 0.138 0.130 0.175 0.158 0.124
Min 0.122 0.117 0.166 0.149 0.116
Max 0.155 0.138 0.178 0.160 0.127
Morbidity Mean 67.80 78.78 75.41 75.31 89.75
Median 66.95 78.60 75.55 74.85 89.50
Min 65.70 77.00 72.40 74.20 88.60
Max 74.60 80.90 77.80 77.20 90.90
4 See for example Gerdtham et al. (1992).
5Recent analyses by the WHO show that countries vary considerably on disease incidences. If individuals in a country get sick
frequently, the need for health care and health spending is usually high (WHO, 2009).
6 See Kanavos and Mossialos (1999) and Gerdtham and Jo¨nsson (2000) for more discussion about the issue.


























Dickey and Fuller (1981). Cointegration is another
application that produces stationarity. Nonetheless, it
is well-known that these tests have low strength
unless the number of observations is large. However,
recent studies that emphasize the low power of
univariate tests have found that stationarity can be
achieved for both healthcare expenditures and GDP
with a panel unit root approach (Blomqvist and
Carter, 1997; McCoskey and Selden, 1998; Gerdtham
and Lothgren, 2000). These findings are questioned
by other researchers in terms of the omission of time
trend in the analyses (Hansen and King, 1996; Jewell
et al., 2003). Most panel tests apply the Im, Pesaran
and Shin (IPS, 1997, 2003) test (e.g. McCoskey and
Selden, 1998), and some include structural breaks
(e.g. Jewell et al., 2003; Carrion-i-Silvestre, 2005).
III. Estimation Results
Stationary process
Following the literature, we start by examining the
stationarity of the variables in our model at the
country level, with a panel approach. A panel
approach improves estimation efficiency by including
a large number of data points in the regression and
utilizing the variation across individuals. We use the
panel approach and employ two specifications of the
Augmented Dickey–Fuller (ADF) equation: first with
individual effects only, then with both individual and
time-specific effects. Including time-specific effects is
no different than allowing for a structural break in
each year that is common to all countries in question.
This inclusion should reflect technological advances,
which lead to large increases in healthcare expendi-
tures.7 New medical techniques and treatments and
innovations in pharmaceutical products, such as the
development of Magnetic Resonance Images (MRIs)
and arthroscopic medical procedures and the intro-
duction of expensive heart diseases drugs, have been
responsible for rising health expenditures. Thus, by
including time-specific effects, we can surrogate
technological improvements in the health sector.8
Table 2 presents the stationarity results for the
change in the share of healthcare expenditures in
GDP (DHCE), the change in GDP per capita
(DGDPK) and the change in the share of public
healthcare expenditures in total healthcare expendi-
tures (DPUBHE).9
We obtained the adjusted t-statistics, stated as LL1
and LL2, after correcting for the negative bias of the
t-values, as Levin and Lin (1992, 1993) suggest.
According to the adjusted t-statistics, the presence of
the unit root is not rejected for all the variables when
individual specific effects are accounted for. Thus,
country-specific variation does not achieve stationar-
ity for the series when panel tests are conducted. The
IPS test also supports this result.
Table 2. Panel unit-root test results including individual and time-specific effects for DHCE, DGDPK and
DPUBHE
Adj.  Adj.  
Specific effects  LL1 LL2 IPS
DHCE
Individual specific effects 2.15 1.10 0.66 1.20
Individual and time-specific effects 13.78 14.10 12.34 2.48
DGDPK
Individual specific effects 2.87 4.52 6.27 1.07
Individual and time-specific effects 30.04 32.28 30.52 1.84
DPUBHE
Individual specific effects 1.45 0.31 1.44 1.18
Individual and time-specific effects 33.84 36.53 34.77 2.36
Notes: Unit-root panel test critical values when specific effects are included for N ¼ 5 and T ¼ 25 are 4.76 and
4.26 at 1% and 5% significance levels, respectively, where N stands for number of countries, and T stands for
time period. Critical values of IPS t-statistics for DF regressions containing only an intercept when N¼ 5 and
T¼ 25 are 2.46 and 2.18 at 1% and 5% significance levels, respectively. Adj.  stands for adjusted t-statistics.
7 Structural breaks specific to individual countries can be captured by other indicators such as public healthcare expenditure,
because such expenditure correlates with fluctuations in the business cycle in that country. We note that IPS tests can be
sensitive to the inclusion of structural breaks and should be approached with a substantial degree of skepticism.
8 See Matteo (2005) for a discussion of the significance of technological innovations.
9 The share of elderly people in the total population and the morbidity variables are stationary; therefore, the differenced
values are also stationary, regardless of the specific effects.


























On the other hand, when both individual and time-
specific effects are included in the model, we achieve
stationarity for all series.10 The results suggest that
while a country-specific effect by itself does not help
us to understand the behaviour of the share of
healthcare expenditures, the per-capita GDP, or the
share of public healthcare expenditures in total
healthcare expenditures, country differences includ-
ing time-specific effects play an important role in
explaining the behaviour of the series.11 Indeed, new
medical technology places further demands on health
systems. For example, the introduction of a new
technology, such as a new drug or operation method,
which can provide opportunities for previously
untreatable patients, would enlarge the potential
market size for health care. Accordingly, in the
remainder of the study, we use the differenced values
of the variables with time-specific effects.
The two-way model
The appropriate specification of the model to esti-
mate the share of healthcare expenditures is as
follows:
DHCEit ¼ 0 þ 1DGDPKit þ 2DPUBHEit
þ 3DOPOPit þ 4DMORBit þ "it
In this model, i denotes the country, t denotes the
year and "it states the disturbance with zero mean and
2 variance. DHCE defines the change in the share of
healthcare expenditures in GDP, DGDPK defines the
change of per-capita GDP and DPUBHE is the
change in the rate of public healthcare expenditures in
the total health expenditures. DOPOP defines the
change in the proportion of people over age 65 in the
total population, and DMORB defines the change in
the morbidity; simply, it indicates whether people
feel better or worse about their health since the
previous year.
Stationary test results showed that we should not
only use the differenced values for the model
variables but also incorporate time-specific effects
into the model. This is because, regardless of the
differencing, the omission of time-specific effects
leads to nonstationary series. Therefore, we applied
the fixed-effects model for a two-factor design
including an overall constant as well as a ‘group’
effect for each group and a ‘time’ effect for each
period. The two-way model produces the estimates in
the same fashion as the one-way model does.
We reported the two-way model results in Table 3,
including both Ordinary Least Squares (OLS) and
Generalized Least Squares (GLS) estimation results
with test statistics. The reason we report both
estimations is that there may be some exogenous
factors omitted from the list of independent variables
Table 3. Panel estimation results with a two-way model
GLS
OLS Fixed effects Random effects Test statistics
Dependent variable: DHCE
Constant 0.2945*** 0.3764*** 0.3646***
(4.71) (5.62) (3.28)
DGDPK 0.16E03*** 0.26E03*** 0.24E0.3*** LM-statistics¼ 22.90
(3.04) (4.03) (4.35) Favours GLS over OLS
DPUBHE 0.0755*** 0.0314 0.0436**
(3.41) (1.61) (2.34)
DOPOP 30.15 23.14 22.78 Hausman’s 2¼ 8.79
(1.45) (1.12) (1.18) Favours GLS random effects model with
a probability value of 0.07
DMORB 0.0257 0.0286* 0.0257*
(1.37) (1.77) (1.66)
Note: *, ** and *** denote significance levels at 10, 5 and 1% levels, respectively.
10 In a simulation study, Karlsson and Lo¨thgren (2000) found that for small-t panels, LL-tests exhibit distortions. However,
based on our results, t-values are large enough to model the series as stationary when time-specific effects are accounted for.
See Maddala and Wu (1999) for arguments about the shortcomings of Levin and Lin tests and of IPS tests and for a
comparison of these two tests with the Fisher test. Also see Banerjee (1999) for an overview and discussion of these tests. Also
see Im et al. (1997) for a power comparison of Levin and Lin tests with t- and LM-tests for different N and T and when errors
are serially correlated.
11 These results are consistent with the studies of Hansen and King (1996) and Jewell et al. (2003).


























or they may be correlated with health expenditures,
and if these variables are not correlated with the
right-hand side variables, both OLS and GLS will be
consistent, but OLS will be inefficient. However, if
these variables are correlated with the right-hand side
variables, OLS is consistent, but GLS is not. The
Lagrange Multiplier (LM) and Hausman’s 2 test
statistics help us to favour one of these models by
testing the orthogonality of the random effects and
the regressors. The null hypothesis states no correla-
tion; thus, low values of the test suggest a statistical
preference for a random-effects model specification.12
The findings suggest three determinants that may
explain the change in the share of healthcare expen-
ditures: First, the change in per-capita GDP has a
negative, significant, but negligible effect on the share
of healthcare expenditures. The data show that the
share of healthcare expenditures in the examined
countries generally increases each year, however, at a
decreasing rate. With the time effect, we observe an
increase in the share of healthcare expenditures with a
slower growth, in the examined countries.13
Second, as the perceived health status of individ-
uals in a country rises, the share of health spending
declines. According to our estimation results, a 1%
rise in the ratio of population responded to the survey
as healthy, lowers the share of healthcare expendi-
tures by 2.57 base points. Indeed, healthy people who
feel they are healthy are generally healthier than
individuals who do not feel they are healthy. One
interesting finding is that the perceived health status
of individuals is an important factor with GDP;
however, the effect of a change in the perceived health
status of individuals is more important to healthcare
expenditures than a change in GDP.
Third, the ratio of public healthcare expenditures
to total healthcare expenditures has a significant
effect on the change in the shares of healthcare
expenditures. An increase in the ratio by 1% is
estimated to increase the share of healthcare
expenditures about 4.36 base points. Public financing
naturally reduces the price paid by the consumers of
medical services. Similar to moral hazard problem in
insurance markets that decline in the price paid by the
consumer might cause the overconsumption of health
care services. Gerdtham and Jo¨nsson (2000) separate
these effects as static and dynamic effects. Faced with
less than full price, consumers tend to utilize health
services even if the benefits are small (Pauly, 1968).
Zweifel (2000) notes that in the health economics
literature static effects are confirmed beyond doubt.
Specifically RAND Health Insurance Experiment
estimated the pure price elasticity for medical care
as 0.2. In addition to that static effect which results
overutilization of health care services there is also a
dynamic effect. Overutilization of health care services
in the short run creates a potential market for new
and more expensive medical technology in the long
run (Weisbrod, 1991). Thus it has been argued that
public financing would increase the demand and thus
expenditure for health care (Leu, 1986). Moreover,
Leu argued that public financing is expected to
increase the medical care spending because of two
more reasons. First one is due to typical incentives of
bureaucrats for maximizing institutional budgets on
public choice literature. Second one is the presumed
inherent inefficiency of public institutions compared
to private companies. However, on the first point
relying on political choice making process arguments
Buchanan (1965)14 suggested the opposite effect of
public financing on health expenditures. Culyer
(1988) noted that private companies are not neces-
sarily more efficient than public agencies. Moreover,
when governments pay a significant portion of health
spending, they might take actions to lower the prices
of health services. Previous empirical studies on that
issue have mixed results.15 Our results suggest that
positive effects of public financing on health spending
is more dominant than negative effects.
12Although our tests suggested that the omission of time-specific effects would lead to a nonstationary process, we also
applied a one-way model. Thus, we included only the country effect in our panel estimation. According to the estimation
results, the morbidity variable provided no statistically significant explanation for the share of healthcare expenditures in
explaining the share of healthcare expenditures. The results suggested that GDP per capita and public share were the only
factors that could explain healthcare expenditures. However, note that the inclusion of time-specific effects into the model in
addition to the country-specific effects greatly improved the test statistics.
13Another way of interpreting a negative coefficient would be to look at short-term effects. When the economy grows quickly,
people may feel healthier and need less medical attention. In addition, the higher opportunity cost of missed working days or
the decrease in productivity due to treatment might encourage individuals to postpone treatment for their health problems.
On the other hand, stagnant economies cause personal stress levels to rise. Indeed, physiological stress is believed to be a
strong trigger for significant health problems, such as diabetes and cancer. Thus, people may need more medical attention but
may spend less on health care when the economy grows quickly.
14His argument is based on political decision-making process.
15 For a study which found negative effect of public financing on medical spending see Gerdtham et al. (1992). For a study
which found positive effect of public financing on medical spending see Leu (1986).



























This article highlights the factors that may explain the
share of healthcare expenditures in the OECD
countries. In addition to the factors used in existing
models, this article adds a relatively direct measure of
healthcare expenditures by using a ‘perceived health
status (morbidity)’ indicator that defines the need for
health care. It also defines the appropriate specifica-
tion of the model and accounts for time-specific
effects when investigating the relationship between
the share of healthcare expenditures and the factors
in question.
Following the attempt to designate the correct
specification of the model, (hence, employing panel
unit root tests), we find that the inclusion of time-
specific effects, which mimics technological advances,
into our panel approach improves the test statistics
greatly when compared to the model that includes
group effects only. In addition, the panel results for
stationary series suggest that in addition to the
change in per-capita GDP, the perceived health
status of individuals also has a significant effect on
the change in the share of health expenditures. As the
perceived health status of individuals in a country
declines, the share of health spending in GDP
increases.
In conclusion, factors that define the need for
health care relatively directly are found to be more
important than per-capita GDP when explaining the
change in the share of healthcare expenditures for the
five examined OECD countries. Among these vari-
ables, an individual-based variable – such as the
change in the morbidity – was more effective in
explaining the share of healthcare expenditures when
compared to the other measures.
One extension of this study could be to examine
such relationship by accounting for the endogeneity
problem. We were aware that estimating the rela-
tionship with OLS would overestimate the slope of
the true relationship, if there was a potential simul-
taneity between the dependent variable and the
regressors. Because healthcare is a normal good, for
example, a higher per-capita GDP increases per-
capita healthcare expenditures. In addition, higher
healthcare expenditures can be regarded as a positive
investment in human capital; and a positive invest-
ment in human capital, as an input to production,
causes an increase in GDP. Healthier individuals are
more energetic and robust physically and mentally,
and thus, more productive. They are also less likely to
be absent from work because of illness. This potential
simultaneity between the two indicators should be
accounted for in empirical studies. Nevertheless,
many studies that analysed the causality between
income and health indicated such a problem
(Chapman and Hariharan, 1994; Devlin and
Hansen, 2001; Nair-Reichert and Weinhold, 2001;
Hurlin, 2004). We also found that this problem exists
for the levels of the series. However, defining the
series in terms of shares and differences eliminated
this problem from our analysis.
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